The store will not work correctly when cookies are disabled.
(2-bromophenyl)(2-hydroxy-4,6-dimethoxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)methanone
ID: ALA1093734
PubChem CID: 46884331
Max Phase: Preclinical
Molecular Formula: C21H25BrN2O4
Molecular Weight: 449.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2ccccc2Br)c(O)c1CN1CCN(C)CC1
Standard InChI: InChI=1S/C21H25BrN2O4/c1-23-8-10-24(11-9-23)13-15-17(27-2)12-18(28-3)19(21(15)26)20(25)14-6-4-5-7-16(14)22/h4-7,12,26H,8-11,13H2,1-3H3
Standard InChI Key: RVLHOTVUKMRJNN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-3.9598 -16.8416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9609 -17.6690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2461 -18.0819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5297 -17.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5325 -16.8380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2479 -16.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6757 -18.0809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3899 -17.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2504 -15.6039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5371 -15.1892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8145 -18.0799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8196 -16.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1036 -16.8326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8227 -15.5978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1038 -17.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3887 -18.0650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3252 -17.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3195 -16.8205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3963 -16.4145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4037 -15.5895 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-3.2463 -18.9069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9609 -19.3192 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6741 -18.9081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3865 -19.3169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3910 -20.1423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6768 -20.5572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9581 -20.1467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1071 -20.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
19 20 1 0
9 10 1 0
3 21 1 0
2 3 1 0
21 22 1 0
22 23 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
12 13 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
1 2 2 0
25 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 449.35 | Molecular Weight (Monoisotopic): 448.0998 | AlogP: 3.15 | #Rotatable Bonds: 6 |
Polar Surface Area: 62.24 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.09 | CX Basic pKa: 7.09 | CX LogP: 3.11 | CX LogD: 2.92 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.68 | Np Likeness Score: -0.29 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |